Kinled Holding

Chairman Patrick Aisher, scion of the Aisher entrepreneurial family, leads investment strategy and capital allocation. Thomas de Camborne Lucy serves as a Director, overseeing certain operational and investment initiatives. The firm follows a concentrated, principal-driven governance model rather than a committee-based institutional structure.

Kinled collaborates with Evotec SE through Danube Labs, a biotech discovery and development platform. The nature of the collaboration and Kinled's specific financial commitment is not publicly detailed. The vehicle aligns with the family office's broader interest in early-stage life sciences, a commitment it shares with its philanthropic arm, CEBINA.

Kinled does not publicly market itself as a co-investor, and there is no disclosed track record of club deals. The accessible portfolio points toward proprietary, directly sourced assets — self-stored Bitcoin, owned real estate on three continents, and a direct biotech collaboration — rather than a fund-of-funds or feeder strategy.

Kinled holds a disclosed Bitcoin position. The office does not publish custody arrangements, size, or acquisition price. The Bitcoin position sits alongside commodity derivatives in the portfolio, suggesting a broader thesis around assets that operate outside traditional equity and fixed-income correlations.

The firm's real estate portfolio includes Chalet Opus in Saanen, Switzerland, a US residential portfolio with properties in Miami, Detroit, Philadelphia, and Chicago, and commercial offices in Hong Kong, London, and New York. The US residential book spans Midwest and East Coast markets, indicating a yield-oriented, multi-market aggregation strategy.